CNTA
Centessa Pharmaceuticals plc ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$26.33
-0.89 ▼ -3.27%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$26.33
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -1.82 | Insider Own | 35.58% | Shs Outstand | 0.13B | Perf Week | 1.46% |
| Market Cap | 3.54B | Forward P/E | - | EPS next Y | -20.33% | Insider Trans | -0.83% | Shs Float | 0.09B | Perf Month | 11.76% |
| Enterprise Value | 3.41B | PEG | - | EPS next Q | -0.37 | Inst Own | 71.86% | Short Float | 7.25% | Perf Quarter | -10.96% |
| Income | -0.24B | P/S | 235.01 | EPS this Y | 33.98% | Inst Trans | 7.41% | Short Ratio | 4.78 | Perf Half Y | 16.14% |
| Sales | 0.02B | P/B | 11.74 | EPS next 5Y | 5.64% | ROA | -45.75% | Short Interest | 6.28M | Perf YTD | 5.28% |
| Book/sh | 2.24 | P/C | 14.38 | EPS past 3/5Y | 21.4% -210.04% | ROE | -60.46% | 52W High | -13.9% ($30.58) | Perf Year | 56.08% |
| Cash/sh | 1.83 | P/FCF | - | Sales past 3/5Y | - | ROIC | -57.75% | 52W Low | 174.27% ($9.60) | Perf 3Y | 594.72% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -18.92% | Gross Margin | 93.96% | Volatility(W/M) | 5.87% 4.94% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 226.52 | Sales Y/Y TTM | 117.83% | Oper. Margin | -1418.34% | ATR (14) | 1.34 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 10.57 | EPS Q/Q | -9.92% | Profit Margin | -1607.47% | RSI (14) | 52.51 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 10.57 | Sales Q/Q | - | SMA20 | 0.51% ($26.2) | Beta | 1.53 | Target Price | $40.38 |
| Payout | - | Debt/Eq | 0.39 | Earnings | 11000000 | SMA50 | 6.47% ($24.73) | Rel Volume | 1.04 | Prev Close | $27.22 |
| Employees | 77 | LT Debt/Eq | 0.39 | EPS/Sales Surpr. | -5.56% -100% | SMA200 | 23.5% ($21.32) | Avg Volume(3M) | 1.31M | Price | $26.33 |
| IPO | 2021/5/28 | Option/Short | Yes/Yes | Trades | 11513 | Volume | 1,362,237 | Change | -3.27% |
뉴스 로딩 중...